Status:
UNKNOWN
Plaque mOrphology iMpact on Side Branch Occlusion at oPtical Coherence Tomography Evaluation in Percutaneous Coronary Interventions
Lead Sponsor:
National Heart Centre Singapore
Conditions:
Bifurcation
Percutaneous Coronary Intervention
Eligibility:
All Genders
21-99 years
Brief Summary
Despite recent advances in interventional cardiology, bifurcation coronary artery stenoses (which account for 15-20% of all coronary lesions treated by PCI), remain a challenge for PCI operators with ...
Detailed Description
We hypothesized that in bifurcation lesion treatment, morphology of the plaque located in the main vessel may impact on the risk of developing SBO. The objectives of POMPEI study as follows: Primary...
Eligibility Criteria
Inclusion
- Age≥21 years of age
- Able to provide consent
- At least one de-novo bifurcation lesion involving a side-branch (SB) ≥ 2mm and SB ostial lesion ≥50% and \<90% by visual assessment intended to be treated by PCI with provisional stenting strategy
- TIMI flow 3 in both MV and SB
Exclusion
- Previous PCI of the target vessel
- Cardiac arrest or cardiogenic shock
- Left main or saphenous venous graft bifurcation
- Significant renal impairment patients (eGFR\<30) who are not on dialysis
- Inability to advance the OCT catheter or to obtain good image quality
Key Trial Info
Start Date :
July 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 14 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04501549
Start Date
July 23 2018
End Date
April 14 2021
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart Centre Singapore
Singapore, Singapore, 169609